Beta Bionics (BBNX) EBT (2024 - 2026)

Beta Bionics has disclosed EBT across 3 years of filings, most recently posting -$23.4 million for Q2 2026.

• In Q2 2026, EBT fell 38.74% year-over-year to -$23.4 million; the TTM figure through Jun 2026 stood at -$73.0 million (down 31.93% YoY), while the FY2025 annual figure was -$60.7 million, down 46.94% from the prior year.
• EBT came in at -$23.4 million for Q2 2026 at Beta Bionics, down from -$21.9 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$8.3 million in Q1 2024 to a low of -$23.4 million in Q2 2026.
• Average EBT over 3 years is -$14.7 million, with a median of -$13.8 million recorded in 2025.
• The largest YoY upside for EBT was 11.42% in 2025 against a maximum downside of 94.92% in 2025.
• Over 3 years, EBT stood at -$12.1 million in 2024, then declined by 11.42% to -$13.5 million in 2025, then plunged by 73.78% to -$23.4 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$23.4 million in Q2 2026, -$21.9 million in Q1 2026, and -$13.5 million in Q4 2025.